Akihisa Imagawa

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Glycemic Control

Monoclonal Antibody

Induced Pluripotent Stem Cells

Top Venues

Journal of diabetes investigation

Diabetology international

This page only lists publications with an associated author ORCID identifier.

Publications

Eiji Kawasaki, Takuya Awata, Hiroshi Ikegami, Akihisa Imagawa, Yoichi Oikawa, Haruhiko Osawa, Takeshi Katsuki, Norio Kanatsuna, Ryoichi Kawamura, Junji Kozawa, Noriko Kodani, Tetsuro Kobayashi, Akira Shimada, Masayuki Shimoda, Kazuma Takahashi, Daisuke Chujo, Tetsuro Tsujimoto, Kyoichiro Tsuchiya, Aiko Terakawa, Jungo Terasaki, Kan Nagasawa, Shinsuke Noso, Tomoyasu Fukui, Ichiro Horie, Kazuki Yasuda, Hisafumi Yasuda, Hidekatsu Yanai, Toshiaki Hanafusa, Hiroshi Kajio, null null
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. Journal of diabetes investigation 15 (7) (2024)
Eiji Kawasaki, Takuya Awata, Hiroshi Ikegami, Akihisa Imagawa, Yoichi Oikawa, Haruhiko Osawa, Takeshi Katsuki, Norio Kanatsuna, Ryoichi Kawamura, Junji Kozawa, Noriko Kodani, Tetsuro Kobayashi, Akira Shimada, Masayuki Shimoda, Kazuma Takahashi, Daisuke Chujo, Tetsuro Tsujimoto, Kyoichiro Tsuchiya, Aiko Terakawa, Jungo Terasaki, Kan Nagasawa, Shinsuke Noso, Tomoyasu Fukui, Ichiro Horie, Kazuki Yasuda, Hisafumi Yasuda, Hidekatsu Yanai, Toshiaki Hanafusa, Hiroshi Kajio, null null
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. Journal of diabetes investigation 15 (7) (2024)
Eiji Kawasaki, Takuya Awata, Hiroshi Ikegami, Akihisa Imagawa, Yoichi Oikawa, Haruhiko Osawa, Takeshi Katsuki, Norio Kanatsuna, Ryoichi Kawamura, Junji Kozawa, Noriko Kodani, Tetsuro Kobayashi, Akira Shimada, Masayuki Shimoda, Kazuma Takahashi, Daisuke Chujo, Tetsuro Tsujimoto, Kyoichiro Tsuchiya, Aiko Terakawa, Jungo Terasaki, Kan Nagasawa, Shinsuke Noso, Tomoyasu Fukui, Ichiro Horie, Kazuki Yasuda, Hisafumi Yasuda, Hidekatsu Yanai, Toshiaki Hanafusa, Hiroshi Kajio, null null
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. Journal of diabetes investigation (2024)
Eiji Kawasaki, Takuya Awata, Hiroshi Ikegami, Akihisa Imagawa, Yoichi Oikawa, Haruhiko Osawa, Takeshi Katsuki, Norio Kanatsuna, Ryoichi Kawamura, Junji Kozawa, Noriko Kodani, Tetsuro Kobayashi, Akira Shimada, Masayuki Shimoda, Kazuma Takahashi, Daisuke Chujo, Tetsuro Tsujimoto, Kyoichiro Tsuchiya, Aiko Terakawa, Jungo Terasaki, Kan Nagasawa, Shinsuke Noso, Tomoyasu Fukui, Ichiro Horie, Kazuki Yasuda, Hisafumi Yasuda, Hidekatsu Yanai, Toshiaki Hanafusa, Hiroshi Kajio, null null
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. Journal of diabetes investigation 15 (7) (2024)
Eiji Kawasaki, Takuya Awata, Hiroshi Ikegami, Akihisa Imagawa, Yoichi Oikawa, Haruhiko Osawa, Takeshi Katsuki, Norio Kanatsuna, Ryoichi Kawamura, Junji Kozawa, Noriko Kodani, Tetsuro Kobayashi, Akira Shimada, Masayuki Shimoda, Kazuma Takahashi, Daisuke Chujo, Tetsuro Tsujimoto, Kyoichiro Tsuchiya, Aiko Terakawa, Jungo Terasaki, Kan Nagasawa, Shinsuke Noso, Tomoyasu Fukui, Ichiro Horie, Kazuki Yasuda, Hisafumi Yasuda, Hidekatsu Yanai, Toshiaki Hanafusa, Hiroshi Kajio, null null
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. Journal of diabetes investigation 15 (7) (2024)
Eiji Kawasaki, Akira Shimada, Akihisa Imagawa, Norio Abiru, Takuya Awata, Yoichi Oikawa, Haruhiko Osawa, Yumiko Kawabata, Junji Kozawa, Tetsuro Kobayashi, Kazuma Takahashi, Daisuke Chujo, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Hiroshi Kajio, Toshiaki Hanafusa, Hiroshi Ikegami, null null
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes. Journal of diabetes investigation (2023)
Eiji Kawasaki, Akira Shimada, Akihisa Imagawa, Norio Abiru, Takuya Awata, Yoichi Oikawa, Haruhiko Osawa, Yumiko Kawabata, Junji Kozawa, Tetsuro Kobayashi, Kazuma Takahashi, Daisuke Chujo, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Hiroshi Kajio, Toshiaki Hanafusa, Hiroshi Ikegami, null null
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes. Journal of diabetes investigation 14 (4) (2023)
Akihisa Imagawa, Toshiaki Hanafusa
Fulminant type 1 diabetes - East and West. The Journal of clinical endocrinology and metabolism (2023)
Eiji Kawasaki, Akira Shimada, Akihisa Imagawa, Norio Abiru, Takuya Awata, Yoichi Oikawa, Haruhiko Osawa, Yumiko Kawabata, Junji Kozawa, Tetsuro Kobayashi, Kazuma Takahashi, Daisuke Chujo, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Hiroshi Kajio, Toshiaki Hanafusa, Hiroshi Ikegami, null null
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes. Journal of diabetes investigation 14 (4) (2023)
Eiji Kawasaki, Akira Shimada, Akihisa Imagawa, Norio Abiru, Takuya Awata, Yoichi Oikawa, Haruhiko Osawa, Yumiko Kawabata, Junji Kozawa, Tetsuro Kobayashi, Kazuma Takahashi, Daisuke Chujo, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Hiroshi Kajio, Toshiaki Hanafusa, Hiroshi Ikegami, null null
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes. Journal of diabetes investigation 14 (4) (2023)
Hiroyuki Sano, Akihisa Imagawa
Research following genome-wide association study focuses on the multifaceted nature of Src kinase-associated phosphoprotein 2 in type 1 diabetes. Journal of diabetes investigation 13 (4) (2022)
Eiji Kawasaki, Akira Shimada, Akihisa Imagawa, Norio Abiru, Takuya Awata, Yoichi Oikawa, Haruhiko Osawa, Yumiko Kawabata, Junji Kozawa, Tetsuro Kobayashi, Kazuma Takahashi, Daisuke Chujo, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Hiroshi Kajio, Toshiaki Hanafusa, Hiroshi Ikegami, null null
Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes. Journal of diabetes investigation (2022)
Akihisa Imagawa
Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor-related and conventional. Journal of diabetes investigation 12 (6) (2020)
Yoshiya Hosakawa, Toshiaki Hanafusa, Akihisa Imagawa
Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research. Journal of diabetes investigation 10 (5) (2019)
Sho Yoneda, Akihisa Imagawa, Yoshiya Hosokawa, Megu Yamaguchi Baden, Takekazu Kimura, Sae Uno, Kenji Fukui, Kunihito Goto, Motohide Uemura, Hidetoshi Eguchi, Hiromi Iwahashi, Junji Kozawa, Iichiro Shimomura
T-Lymphocyte Infiltration to Islets in the Pancreas of a Patient Who Developed Type 1 Diabetes After Administration of Immune Checkpoint Inhibitors. Diabetes care 42 (7) (2019)
Hiroyuki Sano, Akihisa Imagawa
Pancreatic β-cells express major histocompatibility complex class II: Do diabetic β-cells have the capacity of antigen-presenting cells? Journal of diabetes investigation 11 (2) (2019)
Yumiko Kawabata, Nao Nishida, Takuya Awata, Eiji Kawasaki, Akihisa Imagawa, Akira Shimada, Haruhiko Osawa, Shoichiro Tanaka, Kazuma Takahashi, Masao Nagata, Hisafumi Yasuda, Yasuko Uchigata, Hiroshi Kajio, Hideichi Makino, Kazuki Yasuda, Tetsuro Kobayashi, Toshiaki Hanafusa, Katsushi Tokunaga, Hiroshi Ikegami
Genome-Wide Association Study Confirming a Strong Effect of HLA and Identifying Variants in CSAD/lnc-ITGB7-1 on Chromosome 12q13.13 Associated With Susceptibility to Fulminant Type 1 Diabetes. Diabetes 68 (3) (2018)
Megu Yamaguchi Baden, Akihisa Imagawa, Norio Abiru, Takuya Awata, Hiroshi Ikegami, Yasuko Uchigata, Yoichi Oikawa, Haruhiko Osawa, Hiroshi Kajio, Eiji Kawasaki, Yumiko Kawabata, Junji Kozawa, Akira Shimada, Kazuma Takahashi, Shoichiro Tanaka, Daisuke Chujo, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Tetsuro Kobayashi, Toshiaki Hanafusa, null null
Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy. Diabetology international 10 (1) (2018)
Ayumi Tokunaga, Akihisa Imagawa, Hiroshi Nishio, Satoshi Hayata, Iichiro Shimomura, Norio Abiru, Takuya Awata, Hiroshi Ikegami, Yasuko Uchigata, Yoichi Oikawa, Haruhiko Osawa, Hiroshi Kajio, Eiji Kawasaki, Yumiko Kawabata, Junji Kozawa, Akira Shimada, Kazuma Takahashi, Shoichiro Tanaka, Daisuke Chujo, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Tetsuro Kobayashi, Toshiaki Hanafusa, null null
Diffusion-weighted magnetic resonance imaging in the pancreas of fulminant type 1 diabetes. Diabetology international 9 (4) (2018)
Shingo Iwasaki, Junji Kozawa, Takekazu Kimura, Kenji Fukui, Hiromi Iwahashi, Akihisa Imagawa, Iichiro Shimomura
Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir. Diabetology international 8 (2) (2017)